Baseline EGFR/ALK/ROS1 gene mutation detection data of 636 subjects from study HLX10-002-NSCLC301
| Title | Baseline EGFR/ALK/ROS1 gene mutation detection data of 636 subjects from study HLX10-002-NSCLC301 |
|---|---|
| Description | Summary of Baseline EGFR/ALK/ROS1 gene mutation detection data of the intentional treatment set from study HLX10-002-NSCLC301:A Three-Arm, Randomised, Double-Blind, Multicentre, Phase III Clinical Study to Evaluate HLX10 (Recombinant Humanised Anti-PD-1 Monoclonal Antibody Injection) in Combination with Chemotherapy (Carboplatin-Pemetrexed) Versus HLX10 + HLX04 (Recombinant Anti-VEGF Humanised Monoclonal Antibody Injection) in Combination with Chemotherapy (Carboplatin-Pemetrexed) Versus Chemotherapy (Carboplatin-Pemetrexed) as First-Line Treatment of Advanced Non-Squamous Non-Small Cell Lung Cancer (NSCLC).The purpose of this study was to evaluate the clinical efficacy, safety, and tolerability of HLX10 combined chemotherapy and HLX10+HLX04 combined chemotherapy versus chemotherapy in subjects who had not previously received systemic treatment for advanced non-squamous NSCLC, collect PK parameters, and explore biomarkers related to efficacy. |
| Organism | Homo sapiens |
| Data Type | Other Type of Genomic Data |
| Data Accessibility | Controlled-access |
| BioProject | PRJCA018959 |
| Release Date | 2023-08-12 |
| Submitter | Yuankai Shi (syuankaipumc@126.com) |
| Organization | National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences |
| Submission Date | 2023-08-11 |
The data cannot be downloaded as it has not yet been registered in the Human Genetic Resource Management Platform of MOST.
| File ID | File Title | Number/Samples | File Type | File Size | File Suffix | Download Times | Download |
|---|---|---|---|---|---|---|---|
| OMIX004728-01 | Summary of the results of biomarker and gene mutation examination at baseline of the intentional treatment set in HLX10-002-NSCLC301 Study | 1 | Other Type of Genomic Data | 220.4 KB | rtf | 0 | Unavailable |